Protective effects of mefunidone on ischemia-reperfusion injury/Folic acid-induced acute kidney injury

• Main Authors: Jiajia Li (Author), Yupeng Jiang (Author), Qin Dai (Author), Yue Yu (Author), Xin Lv (Author), Yan Zhang (Author), Xiaohua Liao (Author), Liyun Ao (Author), Gaoyun Hu (Author), Jie Meng (Author), Zhangzhe Peng (Author), Lijian Tao (Author), Yanyun Xie (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Renal ischemia-reperfusion injury (IRI) is one of the most common causes of acute kidney injury (AKI). It poses a significant threat to public health, and effective therapeutic drugs are lacking. Mefunidone (MFD) is a new pyridinone drug that exerts a significant protective effect on diabetic nephro...